A revolutionary new approach that analyzes a tiny sample of blood, can detect life-threatening vascular complications in diabetic patients earlier and more accurately than traditional tests.
The first prostate cancer treatment based on the genetic makeup of the cancer resulted in significant improvements, according to a large international trial led by Northwestern Medicine investigators.
Students, faculty and staff gathered to celebrate the Driskill Graduate Program in Life Sciences, welcoming new students and recognizing distinguished upperclassmen and graduates.
The safety of a new therapy for an aggressive brain tumor was demonstrated in a recent clinical trial, and the drug also cleared other important hurdles.
Northwestern Medicine scientists have identified a protein that helps reprogram HER2-positive breast cancer cells to survive in the brain, according to a recent study.
A new blood test can identify early-stage liver cancer, allowing clinicians to start treatment early, according to a new study.
A new study has found that a particularly deadly form of pediatric brain tumor may have a weakness that could inspire future treatments.
Scientists have identified a new gene that can inhibit a multi-protein complex, possibly increasing the risk of cancer, according to a new study published in Science Advances.
Medical student Shivani Baisiwala investigates glioblastoma in the laboratory of Atique Ahmed, PhD, while also pursuing pro-bono healthcare consulting and finding time to explore Chicago’s neighborhoods.
Sheetal Kircher, MD, ’11 GME, is laser-focused on cancer drug distribution and pricing: she spent a year as a health policy fellow at the ASCO and published a paper on the topic in JAMA.